Key Highlights

  • The transaction was valued at an Enterprise value of approximately $5.7 billion.
  • Integer stockholders will receive $127 per share in cash under the terms of the deal.
  • The transaction was announced on August 3, 2026, and approved by stockholders on October 21, 2026.
  • Integer’s common stock has ceased trading and is no longer listed on the New York Stock Exchange.

Integer Holdings Corporation (NYSE:ITGR) announced the completion of its Acquisition by an affiliate of Investment funds managed by KKR, a global investment firm. The Plano, Texas-based company is a medical device contract development and Manufacturing organization, known as a CDMO, and the transaction was valued at an enterprise value of approximately $5.7 billion.

With the closing, Integer’s shares stopped trading and the company is no longer listed on the NYSE. The announcement marks the end of the company’s period as a publicly traded Business and the start of its operation under KKR ownership.

The release did not include a financial table or a forward-looking outlook, consistent with an announcement focused on the completion of the transaction.

Deal Terms and Timeline

The transaction was announced on August 3, 2026, and was approved by Integer stockholders on October 21, 2026. Under its terms, each Integer Shareholder receives $127 per share in cash, a structure that gives holders a fixed cash payment rather than continued exposure to the company’s share price.

The completion followed the stockholder vote and the satisfaction of closing conditions. The company’s release focused on the change in ownership and did not provide new financial results or updated guidance for the period following the closing.

Integer’s transaction was announced in August and needed approval from its stockholders before closing. The release did not describe any remaining conditions after the stockholder vote, and it did not outline a timeline for integration activity under KKR ownership.

Business Profile and Markets Served

Integer describes itself as one of the largest medical device contract development and manufacturing organizations in the world. It serves customers in the cardio and vascular, neuromodulation and cardiac rhythm management markets, providing engineering and manufacturing services to medical device companies.

The company’s brands include Greatbatch Medical and Lake Region Medical. Integer presents itself as a strategic partner to its customers, emphasizing quality, service and innovation in its operations. Those three priorities form the basis of the company’s stated relationship with the device makers it supports.

The company’s services help device makers bring their products to patients, which Integer identifies as the core purpose of its work. Its engineering and manufacturing operations are the basis for the customer relationships it describes in the release.

Integer also points to its work with the world’s leading medical device companies and emerging innovators, a customer base that spans large established manufacturers and smaller developers bringing new products to market.

Management and Sponsor Statements

Payman Khales, Integer’s president and chief executive officer, said the completion opens a new phase for the company and its customers and patients. He said the company expects to accelerate its growth strategy, invest further in its people, capabilities and technologies, and continue supplying devices that serve patients around the world.

Max Lin, a partner at KKR, said the firm sees significant opportunities to use its resources and expertise to support the company’s next phase of growth. He said KKR intends to help expand Integer’s capabilities and strengthen its position in the global medical device industry, working alongside Khales and the management team.

Khales said the company’s customers and employees remain central to the next phase of growth and referenced continued investment in technologies and capabilities. The release did not name specific facilities or product lines targeted for expansion under the new ownership.

Final Word

Integer’s completed acquisition by KKR ends the company’s listing on the New York Stock Exchange and converts the $127 per share cash consideration into the terms for former stockholders. The company was valued at an enterprise value of approximately $5.7 billion in the transaction, which was announced in August and approved in October.

The release did not provide updated financial results, post-closing targets or details on management changes beyond the continuing role of Payman Khales. Future information about the business will come through the new ownership structure rather than through public quarterly filings tied to the NYSE listing.